Neuropsychiatric aspects of Parkinson’s disease: Recent advances

被引：13
|
作者：
Laura Marsh
Ariel Berk
机构：
[1] Johns Hopkins University School of Medicine,Division of Psychiatric Neuroimaging, Geriatric and Neuropsychiatry Programs, Department of Psychiatry and Behavioral Sciences
来源：
Current Psychiatry Reports | 2003年 / 5卷 / 1期
关键词：
Levodopa; Clozapine; Anxiety Disorder; Selegiline; Subthalamic Nucleus;
D O I：
10.1007/s11920-003-0012-6
中图分类号：
学科分类号：
摘要：
Psychiatric disturbances are a common feature of Parkinson’s disease (PD), which is a degenerative disorder defined by its characteristic movement abnormalities. Its management is optimal when PD is viewed as a neuropsychiatric disorder, because this encourages consideration of the motor deficits along with its psychiatric and cognitive aspects. This review addresses the diagnosis and treatment of the most common psychiatric disorders in PD, and provides an update of related clinical research, including studies on neurosurgical treatments.
引用
收藏
页码：68 / 76
页数：8
相关论文
共 50 条
  • [41] Continuous apomorphine infusion and neuropsychiatric disorders: a controlled study in patients with advanced Parkinson’s disease
    A. E. Di Rosa
    A. Epifanio
    A. Antonini
    F. Stocchi
    G. Martino
    L. Di Blasi
    A. Tetto
    G. Basile
    D. Imbesi
    P. La Spina
    G. Di Raimondo
    L. Morgante
    Neurological Sciences, 2003, 24 : 174 - 175
  • [42] Acupuncture for the Treatment of Neuropsychiatric Symptoms in Parkinson's Disease: A Systematic Review and Meta-Analysis
    Zhang, Anxin
    Song, Zefeng
    Di, Anqi
    Zhou, Zelin
    Zheng, Liang
    Zhuang, Lixing
    COMPLEMENTARY THERAPIES IN MEDICINE, 2024, 80
  • [43] Updates and advances in the treatment of Parkinson disease
    Hayes, Michael W.
    Fung, Victor S. C.
    Kimber, Thomas E.
    O'Sullivan, John D.
    MEDICAL JOURNAL OF AUSTRALIA, 2019, 211 (06) : 277 - 283
  • [44] Subthalamotomy in the treatment of Parkinson's disease: clinical aspects and mechanisms of action
    Jourdain, Vincent A.
    Schechtmann, Gaston
    Di Paolo, Therese
    JOURNAL OF NEUROSURGERY, 2014, 120 (01) : 140 - 151
  • [45] Pre-clinical Aspects and Contemporary Treatments of Parkinson's Disease
    Chhabra, Partosh
    Rishabh, Shivani
    Singla, Shivani
    Choudhary, Sunayna
    Kohli, Shivam
    Bansal, Nitin
    Bansal, Seema
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2024, 23 (08) : 996 - 1014
  • [46] Advances in Hydrogel-Based Drug Delivery Systems for Parkinson's Disease
    Nguyen, Thuy Trang
    Bao, Nguyen Si
    Van Vo, Giau
    NEUROCHEMICAL RESEARCH, 2022, 47 (08) : 2129 - 2141
  • [47] Overview of the Extranigral Aspects of Parkinson Disease
    Lim, Shen-Yang
    Fox, Susan H.
    Lang, Anthony E.
    ARCHIVES OF NEUROLOGY, 2009, 66 (02) : 167 - 172
  • [48] Klinik und Therapie der Parkinson-PsychoseClinical aspects and therapy of psychosis in Parkinson's disease
    Walter Pirker
    psychopraxis. neuropraxis, 2015, 18 (5) : 156 - 161
  • [49] The site of stimulation moderates neuropsychiatric symptoms after subthalamic deep brain stimulation for Parkinson's disease
    Mosley, Philip E.
    Smith, David
    Coyne, Terry
    Silburn, Peter
    Breakspear, Michael
    Perry, Alistair
    NEUROIMAGE-CLINICAL, 2018, 18 : 996 - 1006
  • [50] Treatment of early Parkinson's disease
    Pahwa, Rajesh
    Lyons, Kelly E.
    CURRENT OPINION IN NEUROLOGY, 2014, 27 (04) : 442 - 449
12345